In summary, our study provides support for the notion that Blautia-produced acetate can enhance the anti-tumor response of CD8+ T cells in depression-associated breast cancer, shedding light on a potential mechanism through which depression may promote cancer progression. Here, CD8A is linked to depressive symptom measurement.